BOTHELL, Wash., June 5 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it will present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference at the New York Palace Hotel. Michael Matysik, senior vice president and chief financial officer, will review the Company's business strategy and recent financial results during the Company's presentation on Thursday, June 12, 2008 at 2:30 p.m. Eastern Time.
Attendance at the conference is by invitation only. Cardiac Science will offer a live webcast of its presentation, which may be accessed at the Company's website at http://www.cardiacscience.com. An archived replay of the presentation will also be available following the live presentation and can be accessed at http://www.cardiacscience.com for 90 days.
About Cardiac Science
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.
SOURCE Cardiac Science Corporation